title: The impact of folate pathway polymorphisms combined to nutritional deficiency as a maternal predisposition factor for Down syndrome.
abstract: Polymorphisms in genes encoding folate metabolizing enzymes have been linked to an increased risk of maternal chromosomal nondisjunction in several populations. With the purpose of evaluating this relationship, we compared the frequencies of 677C>T and 1298A>C polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR) and 66A>G in the methionine synthase reductase gene (MTRR) between 103 young mothers of Down syndrome (DS) individuals and 108 control mothers, whose offspring was karyotypically normal, correlating it with an estimative of folate and - related micronutrients levels intake. Maternal and paternal transmission frequencies of MTHFR 677T allele were also examined to access potential parent-of-origin effects. PCR-RFLP for genomic DNA was accomplished and allele/genotype frequencies differences were determined using the x(2) test, whereas pattern of transmission of the MTHFR 677 allele was analyzed by transmission disequilibrium test. None of the polymorphisms seemed to be more frequent in case mothers than in controls, either individually or combined. The estimative of nutritional intake revealed that folate consumption median was inadequate in both groups, whereas methionine and zinc consumption medians were significantly greater in control mothers. It suggests that such interaction between genetic profile and environment could predispose this sub group of women to have a DS child. Additional studies focusing the interaction between nutritional intakes, biochemical data and folate pathway polymorphisms are needed to confirm the present results. The possibility of neutralize the biochemical negative effects of folate-related polymorphisms through oral supplementation could provide new targets for DS prevention.
authors.affiliation: Departamento de Genética, Universidade do Estado do Rio de Janeiro, Instituto de Biologia Alcântara Gomes, Serviço de Genética, Rio de Janeiro, RJ, Brazil. cbs@uerj.br
authors.forename: C B
authors.initials: CB
authors.lastname: Santos-Rebouças
authors.forename: J C
authors.initials: JC
authors.lastname: Corrêa
authors.forename: A
authors.initials: A
authors.lastname: Bonomo
authors.forename: N
authors.initials: N
authors.lastname: Fintelman-Rodrigues
authors.forename: K C V
authors.initials: KC
authors.lastname: Moura
authors.forename: C S C
authors.initials: CS
authors.lastname: Rodrigues
authors.forename: J M
authors.initials: JM
authors.lastname: Santos
authors.forename: M M G
authors.initials: MM
authors.lastname: Pimentel
mesh_terms: D000293:Adolescent; D000328:Adult; D000483:Alleles; D016022:Case-Control Studies; D004314:Down Syndrome / Q000209:etiology* / Q000235:genetics* / Q000378:metabolism; D005260:Female; D005287:Ferredoxin-NADP Reductase / Q000235:genetics; D005492:Folic Acid / Q000378:metabolism*; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D044342:Malnutrition / Q000150:complications* / Q000235:genetics / Q000378:metabolism*; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics; D009035:Mothers; D020641:Polymorphism, Single Nucleotide; D011247:Pregnancy; D012307:Risk Factors; D055815:Young Adult
chemical_list: D005492:Folic Acid; C111241:methionine synthase reductase; D005287:Ferredoxin-NADP Reductase; D042965:Methylenetetrahydrofolate Reductase (NADPH2)